Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.78 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.78 |
| ▸ | CACNG2 | Q9Y698 | 1/20 | 0.78 |
| ▸ | ESR1 | P03372 | 2/20 | 0.63 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PRKACA | P17612 | 1/20 | 0.50 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.50 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804992 | 0.92 | ESR2 (0.73) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL16692234 | 0.90 | ESR2 (0.71) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL10041513 | 0.90 | ESR2 (0.71) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL22507259 | 0.90 | GRIA1 (0.73) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL22522291 | 0.90 | GRIA1 (0.73) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL22522307 | 0.90 | GRIA1 (0.73) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL22507301 | 0.90 | GRIA1 (0.73) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL22522309 | 0.89 | GRIA1 (0.77) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL22522532 | 0.89 | GRIA1 (0.77) | GRIA1CACNG8CACNG2ESR1ESR2 | |
| SCHEMBL14160911 | 0.88 | ESR1 (0.73) | GRIA1CACNG8CACNG2ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7193088-B2 | Iridium complexes as light emitting materials and organic light emitting diode device | CHI MEI OPTOELECTRONICS (TW) | 2007-03-20 | — | — | US | disclosed |
| US-7193088-B2 | Iridium complexes as light emitting materials and organic light emitting diode device | CHI MEI OPTOELECTRONICS (TW) | 2007-03-20 | — | — | US | disclosed |
| US-7193088-B2 | Iridium complexes as light emitting materials and organic light emitting diode device | CHI MEI OPTOELECTRONICS (TW) | 2007-03-20 | — | — | US | disclosed |
| US-6936716-B1 | Organometallic complex for organic electroluminescent device | AU OPTRONICS CORP. (TW) | 2005-08-30 | — | — | US | disclosed |
| US-20050116626-A1 | Iridium complexes as light emitting materials and organic light emitting diode device | Innolux Corporation (TW) | 2005-06-02 | — | — | US | disclosed |
| CN-1583772-A | Organometallic complex and organic electroluminescent device including the same | YOUDA PHOTOELECTRIC CO LTD (CN) | 2005-02-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050116626-A1 | Iridium complexes as light emitting materials and organic light emitting diode device | ORC3, CRY1, ITGA1 | GRIA1 206/4885CACNG8 2949/4885CACNG2 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.